112 related articles for article (PubMed ID: 9873524)
1. L-tryptophan urea amides as NK1/NK2 dual antagonists.
Qi H; Shah SK; Cascieri MA; Sadowski SJ; MaCcoss M
Bioorg Med Chem Lett; 1998 Aug; 8(16):2259-62. PubMed ID: 9873524
[TBL] [Abstract][Full Text] [Related]
2. The design and synthesis of novel NK1/NK2 dual antagonists.
Reichard GA; Ball ZT; Aslanian R; Anthes JC; Shih NY; Piwinski JJ
Bioorg Med Chem Lett; 2000 Oct; 10(20):2329-32. PubMed ID: 11055349
[TBL] [Abstract][Full Text] [Related]
3. Spiro-substituted piperidines as neurokinin receptor antagonists. III. Synthesis of (+/-)-N-[2-(3,4-dichlorophenyl)-4-(spiro-substituted piperidin-1'-yl)butyl]-N-methylbenzamides and evaluation of NK1-NK2 dual antagonistic activities.
Kubota H; Kakefuda A; Okamoto Y; Fujii M; Yamamoto O; Yamagiwa Y; Orita M; Ikeda K; Takeuchi M; Shibanuma T; Isomura Y
Chem Pharm Bull (Tokyo); 1998 Oct; 46(10):1538-44. PubMed ID: 9810691
[TBL] [Abstract][Full Text] [Related]
4. Identification of L-tryptophan derivatives with potent and selective antagonist activity at the NK1 receptor.
MacLeod AM; Merchant KJ; Brookfield F; Kelleher F; Stevenson G; Owens AP; Swain CJ; Casiceri MA; Sadowski S; Ber E
J Med Chem; 1994 Apr; 37(9):1269-74. PubMed ID: 7513763
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and NK1/NK2 receptor activity of substituted-4(Z)-(methoxyimino)pentyl-1-piperazines.
Ting PC; Lee JF; Anthes JC; Shih NY; Piwinski JJ
Bioorg Med Chem Lett; 2000 Oct; 10(20):2333-5. PubMed ID: 11055350
[TBL] [Abstract][Full Text] [Related]
6. Discovery of novel, orally active dual NK1/NK2 antagonists.
Bernstein PR; Aharony D; Albert JS; Andisik D; Barthlow HG; Bialecki R; Davenport T; Dedinas RF; Dembofsky BT; Koether G; Kosmider BJ; Kirkland K; Ohnmacht CJ; Potts W; Rumsey WL; Shen L; Shenvi A; Sherwood S; Stollman D; Russell K
Bioorg Med Chem Lett; 2001 Oct; 11(20):2769-73. PubMed ID: 11591520
[TBL] [Abstract][Full Text] [Related]
7. Identification of both NK1 and NK2 receptors in guinea-pig airways.
McKee KT; Millar L; Rodger IW; Metters KM
Br J Pharmacol; 1993 Oct; 110(2):693-700. PubMed ID: 7694756
[TBL] [Abstract][Full Text] [Related]
8. Effects of central administration of tachykinin receptor agonists and antagonists on plus-maze behavior in mice.
Teixeira RM; Santos AR; Ribeiro SJ; Calixto JB; Rae GA; De Lima TC
Eur J Pharmacol; 1996 Sep; 311(1):7-14. PubMed ID: 8884230
[TBL] [Abstract][Full Text] [Related]
9. Rational design of high affinity tachykinin NK1 receptor antagonists.
Boyle S; Guard S; Higginbottom M; Horwell DC; Howson W; McKnight AT; Martin K; Pritchard MC; O'Toole J; Raphy J
Bioorg Med Chem; 1994 May; 2(5):357-70. PubMed ID: 7922147
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of substituted 4(Z)-(methoxyimino)pentyl-1-piperidines as dual NK1/NK2 inhibitors.
Ting PC; Lee JF; Anthes JC; Shih NY; Piwinski JJ
Bioorg Med Chem Lett; 2001 Feb; 11(4):491-4. PubMed ID: 11229755
[TBL] [Abstract][Full Text] [Related]
11. Differential roles of neurokinin 1 and neurokinin 2 receptors in the development and maintenance of heat hyperalgesia induced by acute inflammation.
Sluka KA; Milton MA; Willis WD; Westlund KN
Br J Pharmacol; 1997 Apr; 120(7):1263-73. PubMed ID: 9105701
[TBL] [Abstract][Full Text] [Related]
12. Tachykinin NK1 and NK2 receptor antagonists and atropine-resistant ascending excitatory reflex to the circular muscle of the guinea-pig ileum.
Maggi CA; Patacchini R; Bartho L; Holzer P; Santicioli P
Br J Pharmacol; 1994 May; 112(1):161-8. PubMed ID: 8032637
[TBL] [Abstract][Full Text] [Related]
13. Neurokinin 1 and 2 antagonists attenuate the responses and NK1 antagonists prevent the sensitization of primate spinothalamic tract neurons after intradermal capsaicin.
Dougherty PM; Palecek J; Palecková V; Willis WD
J Neurophysiol; 1994 Oct; 72(4):1464-75. PubMed ID: 7823080
[TBL] [Abstract][Full Text] [Related]
14. In vitro and in vivo pharmacology of S 16474, a novel dual tachykinin NK1 and NK2 receptor antagonist.
Robineau P; Lonchampt M; Kucharczyk N; Krause JE; Regoli D; Fauchere JL; Prost JF; Canet E
Eur J Pharmacol; 1995 Dec; 294(2-3):677-84. PubMed ID: 8750733
[TBL] [Abstract][Full Text] [Related]
15. A flexible approach to the design of new potent substance P receptor ligands.
Millet R; Goossens L; Bertrand-Caumont K; Goossens JF; Houssin R; Hénichart JP
J Pharm Pharmacol; 2001 Jul; 53(7):929-34. PubMed ID: 11480541
[TBL] [Abstract][Full Text] [Related]
16. Comparison of tachykinin NK1 and NK2 receptors in the circular muscle of the guinea-pig ileum and proximal colon.
Maggi CA; Patacchini R; Meini S; Quartara L; Sisto A; Potier E; Giuliani S; Giachetti A
Br J Pharmacol; 1994 May; 112(1):150-60. PubMed ID: 7518302
[TBL] [Abstract][Full Text] [Related]
17. Tachykinin NK1 and NK2 receptors mediate non-adrenergic non-cholinergic excitatory neuromuscular transmission in the guinea-pig stomach.
Zagorodnyuk V; Maggi CA
Neuroscience; 1997 Sep; 80(2):625-34. PubMed ID: 9284363
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of a novel class of non-peptide NK-2 receptor ligand, derived from 1-phenyl-3-pyrrol-1-ylindan-2-carboxamides.
Guillon J; Dallemagne P; Léger JM; Sopkova J; Bovy PR; Jarry C; Rault S
Bioorg Med Chem; 2002 Apr; 10(4):1043-50. PubMed ID: 11836113
[TBL] [Abstract][Full Text] [Related]
19. Implication of NK1 and NK2 receptors in rat colonic hypersecretion induced by interleukin 1 beta: role of nitric oxide.
Eutamene H; Theodorou V; Fioramonti J; Bueno L
Gastroenterology; 1995 Aug; 109(2):483-9. PubMed ID: 7615197
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and structure-activity relationships of oxime neurokinin antagonists: discovery of potent arylamides.
Shih NY; Albanese M; Anthes JC; Carruthers NI; Grice CA; Lin L; Mangiaracina P; Reichard GA; Schwerdt J; Seidl V; Wong SC; Piwinski JJ
Bioorg Med Chem Lett; 2002 Jan; 12(2):141-5. PubMed ID: 11755340
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
